Statement - COVID-19 Business Impact
Siemens Healthineers continues to assess the impact of the COVID-19 pandemic as a priority topic. We are working closely with the NHS and other care providers, as well as our industry partners, to address the unprecedented challenges posed by this crisis. Multiple task force teams across our organisation are meeting daily on the topic, operating at both global and local levels.
In this dynamic and fast moving situation, we remain committed to protecting the health and wellbeing of our employees and others, while continuing to focus on enabling our customers to deliver safe and effective patient care.
We recognise that our customers and their patients are reliant on Siemens Healthineers to provide critical services to support the efforts in combating and treating this disease. We have equipped our workforce to support our customers as productively as possible from home and are enabling critical front-line work to continue where necessary. Additionally, we continue to enhance our infrastructure to quickly address issues remotely in this changing working environment. We are ensuring that we remain agile and pragmatic in responding to the high demands for critical equipment and delivering those solutions as swiftly as possible.
Siemens Healthineers continue to actively monitor both our own and our suppliers‘ operational and manufacturing capabilities to ensure we can provide reliability in a time of uncertainty. Our absolute priority is to support the crisis effort at present. We are proactively working with each customer to optimise support for their situations. At present, we are not experiencing any significant interruptions to supply or delivery due to COVID-19.
Siemens Healthineers remains steadfast in our commitment to the health and safety of everyone, and endeavour to move swiftly and effectively to support the NHS and each other during this time.
At Siemens Healthineers UK, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare.
An estimated five million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services.
We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With about 50,000 dedicated colleagues in over 70 countries, we will continue to innovate and shape the future of healthcare.
We are at the center of clinical decision making across the full healthcare spectrum
Our innovation history
We have a 120-year track record of industry firsts across Siemens Healthineers globally
We are where you are
1Siemens AG, “Sustainable healthcare strategy ‐ Indicators in fiscal 2014”, page 3‐4
2AdvaMedDX, “A Policy Primer on Diagnostics”, June 2011, p. 3.